1st Quarter - Report

VENABLE LLP for ENDO PHARMACEUTICALS INC

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

HR 6165, HR1586 and other tax legislation designed to encourage targeted research and investment in life sciences.

LobbyistCovered position, as disclosed
SAMUEL OLCHYK —
ROBERT L SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1586 (112th), H.R. 6165 (112th)

Pharmacy PHA

General issues affecting the pharmaceutical industry The Life Sciences Investment Act

LobbyistCovered position, as disclosed
ROBERT L SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Drug importation issues (Pharmaceutical Market Access and Drug Safety Act of 2009 Health Care - HR 3590 The Patient Protection and Affordable Health Care Act S. 4018- The Life Sciences Jobs and Investment Act of 2010 H.R. 6165 - The Life Sciences Jobs and Investment Act of 2010

LobbyistCovered position, as disclosed
ROBERT L SMITH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3590 (112th), S. 4018 (112th), H.R. 6165 (112th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.